Taconic, Cellaria partner to facilitate use of patient-derived xenografts for oncolog

[News]

Taconic Biosciences and Cellaria Biosciences today announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria’s novel methodologies for generating cells from patient tumors will complement Taconic’s industry-leading portfolio of tissue humanized mouse models, which are well-suited as hosts for PDXs.

More... (http://www.news-medical.net/news/20150327/Taconic-Cellaria-partner-to-facilitate-use-of-patient-derived-xenografts-for-oncology-research.aspx)